{"id":22,"date":"2020-12-27T09:35:12","date_gmt":"2020-12-27T06:35:12","guid":{"rendered":"https:\/\/www.klimikdergisi.org\/\/?page_id=22"},"modified":"2026-03-10T14:45:46","modified_gmt":"2026-03-10T11:45:46","slug":"yazarlara-bilgi","status":"publish","type":"page","link":"https:\/\/www.klimikdergisi.org\/tr\/yazarlara-bilgi\/","title":{"rendered":"Yazarlara Bilgi"},"content":{"rendered":"<p><em>Klimik Dergisi<\/em>\u2019nin edit\u00f6rl\u00fck ve yay\u0131n s\u00fcre\u00e7leri \u201cInternational Committee of Medical Journal Editors (ICMJE)\u201d, \u201cWorld Association of Medical Editors (WAME)\u201d, \u201cCouncil of Science Editors (CSE)\u201d, \u201cCommittee on Publication Ethics (COPE)\u201d, \u201cEuropean Association of Science Editors (EASE)\u201d ve \u201cNational Information Standards Organization (NISO)\u201d organizasyonlar\u0131n\u0131n k\u0131lavuzlar\u0131na uygun olarak tasarlanm\u0131\u015ft\u0131r ve \u201cPrinciples of Transparency and Best Practice in Scholarly Publishing (doaj.org\/bestpractice)\u201d ilkelerine uygun olarak y\u00fcr\u00fct\u00fclmektedir.<\/p>\n<p><em>Klimik Dergisi<\/em>\u2019nin amac\u0131 infeksiyon hastal\u0131klar\u0131, klinik mikrobiyoloji, viroloji, parazitoloji, imm\u00fcnoloji ve epidemiyoloji alanlar\u0131nda tan\u0131, tedavi ve korunmaya ili\u015fkin y\u00fcksek nitelikli temel ve uygulamal\u0131 ara\u015ft\u0131rma makaleleri yay\u0131mlamakt\u0131r. Ayr\u0131ca derleme, edit\u00f6r g\u00f6r\u00fc\u015f\u00fc, edit\u00f6re mektup ve olgu sunumlar\u0131 da kabul edilmektedir.<\/p>\n<p>Derginin hedef kitlesi, infeksiyon hastal\u0131klar\u0131 ve klinik mikrobiyoloji uzmanlar\u0131 ile infeksiyon hastal\u0131klar\u0131na ilgi duyan t\u00fcm uzmanlar ve pratisyen hekimlerdir.<\/p>\n<p>Ba\u011f\u0131ms\u0131z ve \u00f6nyarg\u0131s\u0131z dan\u0131\u015fmanl\u0131k (peer review) ilkelerine dayanan uluslararas\u0131 bir dergidir. Makaleler dan\u0131\u015fman ve yazar a\u00e7\u0131s\u0131ndan \u201c\u00e7ift k\u00f6r\u201d sistemine g\u00f6re de\u011ferlendirilmektedir.<\/p>\n<p>Ba\u015f edit\u00f6r, makaleleri, yazarlar\u0131n ya\u015f\u0131ndan, etnik k\u00f6keninden, cinsiyetinden, uyru\u011fundan, dini inanc\u0131ndan, cinsel y\u00f6neliminden ve siyasi g\u00f6r\u00fc\u015f\u00fcnden ba\u011f\u0131ms\u0131z olarak de\u011ferlendirir.<\/p>\n<p>Derginin dili T\u00fcrk\u00e7e\u2019dir. Yabanc\u0131 yazarlar\u0131n \u0130ngilizce yaz\u0131lar\u0131na da yer verilebilir.<\/p>\n<p>Dergide yay\u0131mlanacak makaleler i\u00e7in yazarlardan \u00fccret talep edilmez.<\/p>\n<p>Yazarlar makale g\u00f6nderimlerini\u00a0<em>Klimik Dergisi<\/em>\u2019nin online makale kabul sistemi \u00fczerinden yapar. Sisteme y\u00fcklenen makaleler \u00f6ncelikle teknik a\u00e7\u0131dan kontrol edilir. Yaz\u0131m dili, \u015fekil ve tablolar, makaleyle ilgili gerekli belgeler (yazar katk\u0131 formu, telif hakk\u0131 onay formu, olgu sunumlar\u0131 i\u00e7in hasta onam\u0131, etik kurul onay\u0131), kaynak g\u00f6sterimi g\u00f6zden ge\u00e7irilir ve intihal kontrol\u00fc yap\u0131l\u0131r. Bu a\u015famay\u0131 ge\u00e7en makale ba\u015f edit\u00f6re y\u00f6nlendirilir.<\/p>\n<p>Ba\u015f edit\u00f6r makale i\u00e7eri\u011finin dergi yay\u0131n politikas\u0131 ile uyumlu olup olmad\u0131\u011f\u0131n\u0131, dergi yay\u0131n kurallar\u0131na uygun haz\u0131rlan\u0131p haz\u0131rlanmad\u0131\u011f\u0131n\u0131, alana bilimsel katk\u0131s\u0131n\u0131 de\u011ferlendirir.<\/p>\n<p>Bu de\u011ferlendirmeyi ge\u00e7en makaleler bilimsel i\u00e7erik kontrol s\u00fcrecinin ba\u015flat\u0131lmas\u0131 i\u00e7in edit\u00f6re y\u00f6nlendirilir. Edit\u00f6r makalenin bilimsel i\u00e7eri\u011fini de\u011ferlendirmeleri, \u00f6neri, ele\u015ftiri ve katk\u0131lar\u0131n\u0131 bildirmeleri i\u00e7in sistem \u00fczerinden en az iki dan\u0131\u015fman atar. Gerekli g\u00f6rd\u00fc\u011f\u00fc durumlarda ayr\u0131ca \u0130statistik Edit\u00f6r\u00fc\u2019ne de y\u00f6nlendirilebilir.<\/p>\n<p>Dan\u0131\u015fmanlar\u0131n konusunda uzman ki\u015filer aras\u0131ndan, yazarlarla \u00e7\u0131kar \u00e7at\u0131\u015fmas\u0131 olmayan ki\u015filerden se\u00e7ilmesine \u00f6zen g\u00f6sterilir. Makale dan\u0131\u015fmanlara g\u00f6nderilirken herhangi bir yanl\u0131l\u0131\u011f\u0131 engellemek i\u00e7in yazar ve \u00e7al\u0131\u015fman\u0131n yap\u0131ld\u0131\u011f\u0131 kurum bilgileri gizlenir.<\/p>\n<p>Dan\u0131\u015fmanlar\u0131n \u00f6neri, ele\u015ftiri ve katk\u0131lar\u0131 edit\u00f6r taraf\u0131ndan g\u00f6zden ge\u00e7irilir ve yeterli bulundu\u011fu takdirde yazara iletilir. Edit\u00f6r gerekli g\u00f6rd\u00fc\u011f\u00fc durumlarda makaleyi de\u011ferlendirmek \u00fczere ba\u015fka dan\u0131\u015fmanlara da y\u00f6nlendirir. \u00d6neri, ele\u015ftiri ve katk\u0131lar yazarlara iletilirken dan\u0131\u015fman isimleri gizlenir. B\u00f6ylelikle makalelerin bilimsel i\u00e7eri\u011finin \u00e7ift k\u00f6r y\u00f6ntemle, yanl\u0131l\u0131ktan uzak ve objektif bir \u015fekilde de\u011ferlendirilmesi sa\u011flan\u0131r.<\/p>\n<p>Yazarlar\u0131n gerekli d\u00fczenlemeleri yapmalar\u0131n\u0131n ard\u0131ndan makale tekrar edit\u00f6re ve edit\u00f6rden de dan\u0131\u015fmanlara g\u00f6nderilerek yeniden de\u011ferlendirilir. Bu de\u011ferlendirmede yeterli g\u00f6r\u00fclen makaleler yay\u0131mlanmak \u00fczere kabul edilir. Dan\u0131\u015fmanlar\u0131n yay\u0131mlanmaya uygun g\u00f6rmedi\u011fi makaleler reddedilir.<\/p>\n<p>Yay\u0131ma kabul edilen makaleler \u0130ngilizce ve T\u00fcrk\u00e7e dil edit\u00f6rleri taraf\u0131ndan g\u00f6zden ge\u00e7irildikten sonra yay\u0131nc\u0131 taraf\u0131ndan dizilir, makalenin dizilmi\u015f hali son kontrol i\u00e7in yazarlara g\u00f6nderilerek onaylar\u0131 al\u0131n\u0131r. Bu \u015fekilde yay\u0131ma haz\u0131r hale gelen makaleler derginin web sitesinde elektronik olarak yay\u0131mlan\u0131r.<\/p>\n<p>Ara\u015ft\u0131rmalara yap\u0131lan k\u0131smi de olsa nakdi ya da ayni yard\u0131mlar\u0131n hangi kurum, kurulu\u015f, ila\u00e7-gere\u00e7 firmalar\u0131nca yap\u0131ld\u0131\u011f\u0131 dipnot olarak bildirilmelidir.<\/p>\n<p>Yay\u0131mlanmas\u0131 istenen metnin dayand\u0131\u011f\u0131 \u00e7al\u0131\u015fma daha \u00f6nce ba\u015fka bir yerde yay\u0131mlanm\u0131\u015f ya da yay\u0131mlanmak \u00fczere teslim edilmi\u015f veya kabul edilmi\u015f olmamal\u0131d\u0131r. \u00d6zet bi\u00e7iminde yay\u0131mlanm\u0131\u015f bir \u00f6n bildirinin bitmi\u015f bi\u00e7imine yer verilebilir. Yay\u0131mlanmas\u0131 istenen metnin herhangi bir b\u00f6l\u00fcm\u00fcnde \u00e7\u0131kar\u0131lmas\u0131 istenen bir b\u00f6l\u00fcm oldu\u011fu takdirde de yine bir yaz\u0131yla ba\u015fvuru yap\u0131l\u0131r ve gerekli de\u011fi\u015fikli\u011fin yap\u0131lmas\u0131 istenir.<\/p>\n<p>Yay\u0131mlanmas\u0131 istenen metin herhangi bir nedenle yazar(lar)ca geri \u00e7ekilmek istenirse nedenleri a\u00e7\u0131klayan bir yaz\u0131yla ba\u015fvuru yap\u0131l\u0131r.<\/p>\n<p>Yazarlar\u0131n \u00e7al\u0131\u015ft\u0131klar\u0131 kurumun ad\u0131ndan ve ara\u015ft\u0131rman\u0131n ger\u00e7ekle\u015fti\u011fi b\u00f6l\u00fcm veya kurumun ad\u0131ndan ana metinde s\u00f6z edilmemelidir.<\/p>\n<p>\u0130leti\u015fimi y\u00fcr\u00fcten yazar ileti\u015fim bilgilerini a\u00e7\u0131k\u00e7a belirtmelidir (telefon numaras\u0131, faks numaras\u0131 ve e-posta adresi). \u0130leti\u015fimi y\u00fcr\u00fcten yazarlar\u0131n bilgileri, dergide yay\u0131mlanmaktad\u0131r.<\/p>\n<p>Yazarlar yay\u0131mlanmak \u00fczere teslim ettikleri her \u015feyin bir kopyas\u0131n\u0131 saklamal\u0131d\u0131r.<\/p>\n<p>Teslim edilmi\u015f bir metnin t\u00fcm\u00fcn\u00fcn veya bir b\u00f6l\u00fcm\u00fcn\u00fcn ba\u015fka bir yerde yay\u0131mlanmas\u0131 s\u00f6z konusu olursa Edit\u00f6r Ofisine bilgi verilmesi zorunludur.<\/p>\n<h2 class=\"p4\"><b>YAPAY ZEK<strong>\u00c2<\/strong> KULLANIM BEYANI<\/b><\/h2>\n<p><em>Klimik Dergisi<\/em>\u2019ne g\u00f6nderilen makalelerin haz\u0131rlanmas\u0131 s\u00fcrecinde yapay zek\u00e2 destekli ara\u00e7lardan yararlan\u0131lm\u0131\u015fsa bu durum a\u00e7\u0131k\u00e7a beyan edilmelidir. Yapay zek\u00e2 ara\u00e7lar\u0131 yaln\u0131zca dil d\u00fczenleme, yaz\u0131m ve dilbilgisi d\u00fczeltmeleri gibi yard\u0131mc\u0131 ama\u00e7larla kullan\u0131labilir. \u00c7al\u0131\u015fman\u0131n bilimsel i\u00e7eri\u011fi, veri analizi, yorumlanmas\u0131 ve sonu\u00e7lar\u0131ndan tamamen yazarlar sorumludur. Yapay zek\u00e2 ara\u00e7lar\u0131 yazar olarak g\u00f6sterilemez.<\/p>\n<p>Yazarlar yapay zek\u00e2 kullan\u0131m\u0131na ili\u015fkin bilgiyi ba\u015fl\u0131k sayfas\u0131nda \u201cYapay Zek\u00e2 Beyan\u0131 \/ Artificial Intelligence Statement\u201d ba\u015fl\u0131\u011f\u0131 alt\u0131nda belirtmelidir. Yapay zek\u00e2 ara\u00e7lar\u0131n\u0131n kullan\u0131lmad\u0131\u011f\u0131 durumlarda da bu durum a\u00e7\u0131k\u00e7a ifade edilmelidir.<\/p>\n<h2 class=\"p4\"><b>TEL\u0130F HAKKI<\/b><\/h2>\n<p>Yazarlar,\u00a0<em>Klimik Dergisi<\/em>\u2019nde makalelerinin yay\u0131nlanmas\u0131 i\u00e7in\u00a0<a href=\"https:\/\/www.klimikdergisi.org\/wp-content\/uploads\/2021\/05\/THO.FORMU_.pdf\"><strong>Telif Hakk\u0131 Onay Formu\u2019<\/strong><\/a>nu doldurarak online makale kabul sistemine y\u00fcklemelidir. Yazarlar, Telif Hakk\u0131 Onay Formu\u2019nu imzalad\u0131klar\u0131nda makalelerinin\u00a0<em>Klimik Dergisi<\/em>\u2019nde yay\u0131mlanmas\u0131 halinde \u201cCreative Commons Attribution-Non Commercial 4.0 International License (<a href=\"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/deed.en\"><strong>CC-BY-NC 4.0<\/strong><\/a>)\u201d uygulamalar\u0131na tabi olaca\u011f\u0131n\u0131 kabul etmi\u015f olurlar.<\/p>\n<p><a href=\"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/deed.en\"><strong>CC BY-NC 4.0<\/strong><\/a>\u00a0lisans\u0131, eserin ticari kullan\u0131m d\u0131\u015f\u0131nda her boyut ve formatta payla\u015f\u0131lmas\u0131na, kopyalanmas\u0131na, \u00e7o\u011falt\u0131lmas\u0131na ve orijinal esere uygun \u015fekilde at\u0131fta bulunmak kayd\u0131yla yeniden d\u00fczenleme, d\u00f6n\u00fc\u015ft\u00fcrme ve eserin \u00fczerine in\u015fa etme d\u00e2hil adapte edilmesine izin verir.<\/p>\n<p>\u015eekiller, tablolar veya hem bas\u0131l\u0131 hem de elektronik formattaki di\u011fer materyaller dahil olmak \u00fczere daha \u00f6nce yay\u0131nlanm\u0131\u015f i\u00e7eri\u011fi kullan\u0131rken, yazarlar telif hakk\u0131 sahibinden izin almal\u0131d\u0131r. Bu konudaki hukuki, mali ve cezai sorumluluk yazar(lar)a aittir.<\/p>\n<p><em>Klimik Dergisi\u2019<\/em>nde yay\u0131mlanan t\u00fcm yaz\u0131lardaki g\u00f6r\u00fc\u015f ve raporlar yazar(lar)\u0131n g\u00f6r\u00fc\u015f\u00fcd\u00fcr. Bu nedenle, T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 (KL\u0130M\u0130K) Derne\u011fi, Edit\u00f6r, Yay\u0131n Kurulu ve Yay\u0131nc\u0131 bu yaz\u0131lar i\u00e7in herhangi bir sorumluluk kabul etmemektedir.<\/p>\n<h2 class=\"p4\"><b>YAYIN SONRASI D\u00dcZELTMELER<\/b><\/h2>\n<p><em>Klimik Dergisi<\/em>, yay\u0131mlanm\u0131\u015f makalelerde bilimsel do\u011frulu\u011fun korunmas\u0131n\u0131 temel bir yay\u0131n ilkesi olarak kabul eder. Yay\u0131mlanm\u0131\u015f bir makalede anlam\u0131 etkileyebilecek hata veya eksikliklerin saptanmas\u0131 durumunda gerekli g\u00f6r\u00fcld\u00fc\u011f\u00fcnde d\u00fczeltme (correction) yay\u0131mlanabilir.<\/p>\n<p>D\u00fczeltmeler, ilgili makaleye a\u00e7\u0131k bi\u00e7imde at\u0131f yap\u0131larak ve d\u00fczeltilen bilginin ayr\u0131nt\u0131lar\u0131 belirtilerek derginin \u00e7evrimi\u00e7i s\u00fcr\u00fcm\u00fcnde yay\u0131mlan\u0131r ve ilgili makale ile elektronik ba\u011flant\u0131 kurulur.<\/p>\n<p>Yazarlar\u0131n yay\u0131mlanm\u0131\u015f bir makalede hata fark etmeleri durumunda durumu en k\u0131sa s\u00fcrede dergi edit\u00f6rl\u00fc\u011f\u00fcne bildirmeleri beklenir. Bilimsel bulgular\u0131n g\u00fcvenilirli\u011fini \u00f6nemli \u00f6l\u00e7\u00fcde etkileyen durumlarda edit\u00f6r uluslararas\u0131 yay\u0131n eti\u011fi ilkeleri do\u011frultusunda editoryal a\u00e7\u0131klama (editorial note) veya geri \u00e7ekme (retraction) s\u00fcre\u00e7lerini ba\u015flatabilir.<\/p>\n<h2 class=\"p4\"><b>YAZAR KATKISI<\/b><\/h2>\n<p>Makalede yazar olarak yer alan her bir ki\u015finin\u00a0\u201cInternational Committee of Medical Journal Editors (ICMJE)\u201dnin \u00f6nerdi\u011fi yazarl\u0131k kriterlerini kar\u015f\u0131lam\u0131\u015f olmas\u0131 beklenir (ICMJE \u2013<strong>\u00a0<\/strong><a href=\"http:\/\/www.icmje.org\/\"><strong>www.icmje.org<\/strong><\/a>).<\/p>\n<p>ICMJE, yazarlar\u0131n a\u015fa\u011f\u0131daki d\u00f6rt ko\u015fulu kar\u015f\u0131lamas\u0131n\u0131 \u00f6nermektedir:<\/p>\n<ul>\n<li>\u00c7al\u0131\u015fman\u0131n konseptine\/tasar\u0131m\u0131na; ya da \u00e7al\u0131\u015fma i\u00e7in verilerin toplanmas\u0131na, analiz edilmesine ve yorumlanmas\u0131na \u00f6nemli katk\u0131 sa\u011flam\u0131\u015f olmak,<\/li>\n<li>Yaz\u0131 tasla\u011f\u0131n\u0131 haz\u0131rlam\u0131\u015f ya da \u00f6nemli fikirsel i\u00e7eri\u011fin ele\u015ftirel incelemelerini yapm\u0131\u015f olmak,<\/li>\n<li>Yaz\u0131n\u0131n yay\u0131ndan \u00f6nceki son halini g\u00f6zden ge\u00e7irmi\u015f ve onaylam\u0131\u015f olmak,<\/li>\n<li>\u00c7al\u0131\u015fman\u0131n herhangi bir b\u00f6l\u00fcm\u00fcn\u00fcn ge\u00e7erlili\u011fi ve do\u011frulu\u011funa ili\u015fkin sorular\u0131n uygun \u015fekilde soru\u015fturuldu\u011funun ve \u00e7\u00f6z\u00fcmlendi\u011finin garantisini vermek amac\u0131yla \u00e7al\u0131\u015fman\u0131n her y\u00f6n\u00fcnden sorumlu olmay\u0131 kabul etmek.<\/li>\n<\/ul>\n<p>\u0130leti\u015fim kurulacak yazar makalenin y\u00fcklenmesi s\u0131ras\u0131nda her bir yazar\u0131n makaleye hangi a\u015famalarda ve ne kadar katk\u0131da bulundu\u011funu g\u00f6steren\u00a0<a href=\"https:\/\/www.klimikdergisi.org\/wp-content\/uploads\/2021\/05\/YK.FORMU_.pdf\"><strong>Yazar Katk\u0131 Formunu<\/strong><\/a>\u00a0doldurarak\u00a0online makale kabul sistemine\u00a0y\u00fcklemelidir.<\/p>\n<h2 class=\"p4\"><b>YAZIM KURALLARI<\/b><\/h2>\n<p>Makaleler a\u015fa\u011f\u0131da makale tiplerine g\u00f6re belirlenmi\u015f b\u00f6l\u00fcmlere ayr\u0131l\u0131r. Her bir b\u00f6l\u00fcm ayr\u0131 sayfada yer al\u0131r:\u00a0\u00a0Ba\u015fl\u0131k sayfas\u0131, \u00f6zet ve anahtar s\u00f6zc\u00fckler (T\u00fcrk\u00e7e ve \u0130ngilizce), ana metin, kaynaklar, tablolar\/\u015fekiller\/resimler (her tablo ba\u015fl\u0131k ve dipnotlar\u0131yla birlikte ayr\u0131 bir sayfaya yaz\u0131lmal\u0131d\u0131r), \u015fekil ve resim altyaz\u0131lar\u0131.<\/p>\n<p>Ba\u015fl\u0131k sayfas\u0131nda b\u00fct\u00fcn makale t\u00fcrlerinde standard olarak a\u015fa\u011f\u0131daki bilgiler yer almal\u0131d\u0131r:<\/p>\n<ul>\n<li>T\u00fcrk\u00e7e Ba\u015fl\u0131k, T\u00fcrk\u00e7e K\u0131sa Ba\u015fl\u0131k,<\/li>\n<li>\u0130ngilizce Ba\u015fl\u0131k ve \u0130ngilizce K\u0131sa Ba\u015fl\u0131k<\/li>\n<\/ul>\n<p>Makalenin b\u00fct\u00fcn b\u00f6l\u00fcmlerinin ba\u015fl\u0131k, \u00f6zet, ana metin, te\u015fekk\u00fcr, tablolar, \u015fekil ve resim altyaz\u0131lar\u0131 dahil iki bo\u015fluklu ve 12 punto olarak yaz\u0131lmas\u0131 gerekir. Yeterli sayfa kenar\u0131 bo\u015flu\u011fu b\u0131rak\u0131lmal\u0131d\u0131r. Yazarlar ba\u015fl\u0131k sayfas\u0131ndan itibaren makalenin t\u00fcm sayfalar\u0131n\u0131 s\u0131ras\u0131yla numaraland\u0131rmal\u0131d\u0131r. Ayr\u0131ca ana metinde sat\u0131r numaralar\u0131 verilmelidir.<\/p>\n<p>Makalelerin ba\u015fl\u0131\u011f\u0131 bilgi eksikli\u011fine yol a\u00e7mamak ko\u015fuluyla \u00e7ok uzun olmamal\u0131d\u0131r.<\/p>\n<p>Dergimize yay\u0131mlanmak \u00fczere g\u00f6nderilen ve de\u011ferlendirme sonucunda yay\u0131ma kabul edilen makalelerdeki yaz\u0131m ve dilbilgisi hatalar\u0131, makalenin i\u00e7eri\u011fine dokunmadan d\u00fczeltilmektedir. Yazarlar bu d\u00fczeltmeleri kabul etmi\u015f say\u0131l\u0131rlar.<\/p>\n<p>Anahtar s\u00f6zc\u00fckler, \u201cMedical Subject Headings\u201de uygun olarak verilmelidir (<strong><a href=\"https:\/\/www.nlm.nih.gov\/mesh\/meshhome.html\">https:\/\/www.nlm.nih.gov\/mesh\/Mbrowser.html)<\/a><\/strong><\/p>\n<h2 class=\"p6\"><b>\u0130STAT\u0130ST\u0130KSEL ANAL\u0130ZLER<\/b><\/h2>\n<p><em>Klimik Dergisi<\/em>\u2019nin istatistik edit\u00f6r\u00fc olmakla birlikte orijinal makalelerde istatistik analiz yap\u0131l\u0131rken ve sonu\u00e7lar bildirilirken a\u015fa\u011f\u0131daki kurallara uyulmas\u0131 gereksiz zaman kayb\u0131n\u0131 azaltaca\u011f\u0131 gibi makalenin anla\u015f\u0131l\u0131rl\u0131\u011f\u0131n\u0131 da art\u0131racakt\u0131r. \u0130statistiksel analizlerin yap\u0131lmas\u0131 ve sonu\u00e7lar\u0131n raporlanmas\u0131, Altman ve ark. taraf\u0131ndan yay\u0131mlanan <em data-start=\"346\" data-end=\"407\">Statistical Guidelines for Contributors to Medical Journals<\/em> ba\u015fl\u0131kl\u0131 makalede belirtilen ilkelere uygun olarak ger\u00e7ekle\u015ftirilmelidir (BMJ. 1983;286:1489\u201393). Analizde kullan\u0131lan yaz\u0131l\u0131m\u0131n ad\u0131 ve s\u00fcr\u00fcm\u00fc belirtilmelidir. S\u00fcrekli de\u011fi\u015fkenlerin kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131 i\u00e7in parametrik test gerekti\u011fi durumda sonu\u00e7lar ortalama \u00b1 standard sapma olarak verilmeli, non-parametrik testler gerekti\u011fi durumda ise sonu\u00e7lar \u201cmedyan (minimum-maksimum de\u011ferler)\u201d \u015feklinde veya %\u2019lik dilimler ve dilimler aras\u0131 sal\u0131n\u0131m (IQR) olarak verilmelidir. R\u00f6latif risk (RR), \u201codds\u201d oran\u0131 (OR) veya hazard oran\u0131 (HR) verilece\u011fi zaman sadece \u201c<em>p<\/em>\u00a0de\u011feri\u201d de\u011fil mutlaka g\u00fcven aral\u0131klar\u0131 da verilmelidir.<\/p>\n<h2 class=\"p4\"><b>MAKALE T\u00dcRLER\u0130<\/b><\/h2>\n<h3 class=\"p6\"><b>\u00d6zg\u00fcn Ara\u015ft\u0131rma<\/b><\/h3>\n<p>\u00d6zg\u00fcn ara\u015ft\u0131rma t\u00fcr\u00fcndeki bir makale a\u015fa\u011f\u0131daki gibi haz\u0131rlanmal\u0131d\u0131r:<\/p>\n<ul>\n<li>Ba\u015fl\u0131k sayfas\u0131.<\/li>\n<li>Yap\u0131land\u0131r\u0131lm\u0131\u015f (ama\u00e7, y\u00f6ntemler, bulgular, sonu\u00e7) T\u00fcrk\u00e7e \u00f6zet (en fazla 300 kelime) ve yap\u0131land\u0131r\u0131lm\u0131\u015f (objective, methods, results, conclusion) \u0130ngilizce \u00f6zet (en fazla 300 kelime) haz\u0131rlanmal\u0131d\u0131r.<\/li>\n<li>T\u00fcrk\u00e7e ve \u0130ngilizce anahtar kelimeler (en az 3 en \u00e7ok 6 adet ve Ulusal T\u0131p K\u00fct\u00fcphanesi (NLM) taraf\u0131ndan haz\u0131rlanan T\u0131bbi Konu Ba\u015fl\u0131klar\u0131 (MeSH) ile uyumlu olmak \u00fczere).<\/li>\n<li><strong>Ana Metin: <\/strong>Kaynaklar hari\u00e7 5000 kelimeyi a\u015fmamal\u0131d\u0131r. Giri\u015f, Y\u00f6ntemler, Bulgular, \u0130rdeleme b\u00f6l\u00fcmlerine ayr\u0131lm\u0131\u015f olmal\u0131d\u0131r. Gerekti\u011finde \u201cY\u00f6ntemler\u201d ve \u201cBulgular\u201d b\u00f6l\u00fcmleri alt ba\u015fl\u0131klara ayr\u0131labilir. Etik kurul izninin al\u0131nd\u0131\u011f\u0131 kurul ve tarih\/say\u0131s\u0131 Y\u00f6ntemler k\u0131sm\u0131nda yer almal\u0131d\u0131r.<\/li>\n<li>Te\u015fekk\u00fcr (istenirse).<\/li>\n<li>\u00c7\u0131kar \u00e7at\u0131\u015fmas\u0131 beyan\u0131.<\/li>\n<li>Yazarlar\u0131n \u00e7al\u0131\u015fmaya\/yaz\u0131ya katk\u0131lar\u0131.<\/li>\n<li><strong>Kaynaklar:<\/strong>A\u015fa\u011f\u0131da ayr\u0131nt\u0131s\u0131 verildi\u011fi \u015fekilde g\u00f6sterilmeli ve say\u0131ca 50\u2019yi a\u015fmamal\u0131d\u0131r.<\/li>\n<li><strong>Tablo, \u015eekil ve Resimler:\u00a0<\/strong>E\u011fer varsa metindeki ge\u00e7i\u015flerine g\u00f6re s\u0131ras\u0131yla numaraland\u0131r\u0131lmal\u0131d\u0131r; her birine k\u0131sa bir ba\u015fl\u0131k verilmeli ve ba\u015fl\u0131k tablolarda \u00fcst k\u0131sma, \u015fekil ve resimlerde alta yerle\u015ftirilmelidir.<\/li>\n<\/ul>\n<h3 class=\"p6\"><b>Olgu Sunumu<\/b><\/h3>\n<p>Dergide s\u0131n\u0131rl\u0131 say\u0131da olgu sunumu i\u00e7in yer ayr\u0131ld\u0131\u011f\u0131ndan sadece tan\u0131 veya tedavide g\u00fc\u00e7l\u00fck olan nadir g\u00f6r\u00fclen olgular veya e\u011fitsel a\u00e7\u0131dan de\u011ferli, klasik bilgiler aras\u0131nda yer almayan bilgi i\u00e7eren, ilgin\u00e7 olarak de\u011ferlendirilebilecek olgular kabul edilecektir.<\/p>\n<p>Olgu sunumu t\u00fcr\u00fcndeki bir makale a\u015fa\u011f\u0131daki gibi haz\u0131rlanmal\u0131d\u0131r:<\/p>\n<ul>\n<li>Ba\u015fl\u0131k sayfas\u0131.<\/li>\n<li>Yap\u0131land\u0131r\u0131lmam\u0131\u015f T\u00fcrk\u00e7e \u00f6zet ve \u0130ngilizce \u00f6zet (her biri en fazla 150 kelime) haz\u0131rlanmal\u0131d\u0131r.<\/li>\n<li>T\u00fcrk\u00e7e ve \u0130ngilizce anahtar kelimeler (en az 2 en \u00e7ok 4 adet ve Ulusal T\u0131p K\u00fct\u00fcphanesi (NLM) taraf\u0131ndan haz\u0131rlanan T\u0131bbi Konu Ba\u015fl\u0131klar\u0131 (MeSH) ile uyumlu olmak \u00fczere).<\/li>\n<li><strong>Ana Metin: <\/strong>\u201cGiri\u015f, Olgu(lar), \u0130rdeleme\u201d b\u00f6l\u00fcmlerine ayr\u0131lm\u0131\u015f \u015fekilde yap\u0131land\u0131r\u0131lm\u0131\u015f olmal\u0131 ve en \u00e7ok 1500 kelime i\u00e7ermelidir.<\/li>\n<li><strong>Kaynaklar: <\/strong>A\u015fa\u011f\u0131da ayr\u0131nt\u0131s\u0131 verildi\u011fi \u015fekilde g\u00f6sterilmeli ve say\u0131ca 10\u2019u a\u015fmamal\u0131d\u0131r.<\/li>\n<li><strong>Tablo, \u015eekil ve Resimler: <\/strong>E\u011fer varsa metindeki ge\u00e7i\u015flerine g\u00f6re s\u0131ras\u0131yla numaraland\u0131r\u0131lmal\u0131d\u0131r; her birine k\u0131sa bir ba\u015fl\u0131k verilmeli ve ba\u015fl\u0131k tablolarda \u00fcst k\u0131sma, \u015fekil ve resimlerde alta yerle\u015ftirilmelidir.<\/li>\n<\/ul>\n<h3 class=\"p6\"><b>Derleme<\/b><\/h3>\n<p><em>Klimik Dergisi<\/em>, alan\u0131nda derinlemesine bilgi sahibi olan, mesleki hayat\u0131nda belli bir alanda y\u00fcr\u00fctt\u00fc\u011f\u00fc \u00e7al\u0131\u015fmalarla ulusal ve uluslararas\u0131 alanda tan\u0131nm\u0131\u015f, o alanda \u00e7ok say\u0131da at\u0131f alan yay\u0131n\u0131 bulunan ki\u015filerden Ba\u015f Edit\u00f6r\u00fcn daveti ile derleme yaz\u0131 kabul etmektedir. Derlemelerin, belli bir ba\u015fl\u0131kta insanl\u0131\u011f\u0131n mevcut bilgi d\u00fczeyini \u00f6zetleyerek bilgi a\u00e7\u0131\u011f\u0131n\u0131 ortaya koymas\u0131 ve gelecek \u00e7al\u0131\u015fmalara \u0131\u015f\u0131k tutmas\u0131, infeksiyon hastal\u0131klar\u0131 ve klinik mikrobiyoloji alan\u0131nda \u00e7al\u0131\u015fanlara ufuk a\u00e7mas\u0131 beklenmektedir.<\/p>\n<p>Derleme t\u00fcr\u00fcndeki bir makale a\u015fa\u011f\u0131daki gibi haz\u0131rlanmal\u0131d\u0131r:<\/p>\n<ul>\n<li>Ba\u015fl\u0131k sayfas\u0131.<\/li>\n<li>Yap\u0131land\u0131r\u0131lmam\u0131\u015f T\u00fcrk\u00e7e \u00f6zet ve \u0130ngilizce \u00f6zet (her biri en fazla 150 kelime) haz\u0131rlanmal\u0131d\u0131r.<\/li>\n<li>T\u00fcrk\u00e7e ve \u0130ngilizce anahtar kelimeler (en az 3 en \u00e7ok 6 adet ve Ulusal T\u0131p K\u00fct\u00fcphanesi (NLM) taraf\u0131ndan haz\u0131rlanan T\u0131bbi Konu Ba\u015fl\u0131klar\u0131 (MeSH) ile uyumlu olmak \u00fczere)<\/li>\n<li><strong>\u00d6ne \u00c7\u0131kanlar: <\/strong>Derlemeye konu alandaki mevcut bilginin, klinik pratik a\u00e7\u0131s\u0131ndan ve\/veya bilimsel geli\u015fme a\u00e7\u0131s\u0131ndan en \u00f6nemli ba\u015fl\u0131klar\u0131n\u0131, cevaplanmam\u0131\u015f en \u00f6nemli sorular\u0131 ve\/veya gelece\u011fe ili\u015fkin bilimsel \u00f6ng\u00f6r\u00fcleri i\u00e7eren 4\u20135 maddelik bir b\u00f6l\u00fcm olup en fazla 150 kelimeden olu\u015fmal\u0131d\u0131r.<\/li>\n<li><strong>Ana Metin: <\/strong>Derleme makalede ana metin yazar\u0131n uygun g\u00f6rd\u00fc\u011f\u00fc \u015fekilde alt ba\u015fl\u0131klara ayr\u0131labilir.<\/li>\n<li><strong>Kaynaklar: <\/strong>A\u015fa\u011f\u0131da ayr\u0131nt\u0131s\u0131 verildi\u011fi \u015fekilde g\u00f6sterilmeli ve say\u0131ca 75\u2019i a\u015fmamal\u0131d\u0131r.<\/li>\n<li><strong>Tablo, \u015eekil ve Resimler: <\/strong>E\u011fer varsa metindeki ge\u00e7i\u015flerine g\u00f6re s\u0131ras\u0131yla numaraland\u0131r\u0131lmal\u0131d\u0131r; her birine k\u0131sa bir ba\u015fl\u0131k verilmeli ve ba\u015fl\u0131k tablolarda \u00fcst k\u0131sma, \u015fekil ve resimlerde alta yerle\u015ftirilmelidir.<\/li>\n<\/ul>\n<h3><strong>Uzla\u015f\u0131 Raporu ve Rehber<\/strong><\/h3>\n<p><em>Klimik Dergisi<\/em>, infeksiyon hastal\u0131klar\u0131 ve mikrobiyoloji alan\u0131ndaki hastal\u0131klar\u0131n tan\u0131s\u0131, tedavisi ve \u00f6nlenmesine ili\u015fkin uzla\u015f\u0131 raporu ve rehber niteli\u011findeki yaz\u0131lar\u0131 kabul etmektedir. Farkl\u0131 deneyimlere, yetkinliklere ve bak\u0131\u015f a\u00e7\u0131lar\u0131na sahip uzmanlar\u0131n geni\u015f kat\u0131l\u0131m\u0131yla haz\u0131rlanan s\u00f6z konusu yaz\u0131lar \u00f6nceliklerin belirlenmesine, klinik tavsiyelerin netle\u015ftirilmesine ve politika olu\u015fturulabilmesine destek olmak i\u00e7in haz\u0131rlan\u0131rlar. Bu anlay\u0131\u015fla ve geni\u015f bir kat\u0131l\u0131mla, g\u00fcncel bilimsel bilgi ve kan\u0131tlar\u0131n de\u011ferlendirilmesi, \u00fczerinde uzla\u015f\u0131lm\u0131\u015f bir metin olarak ortaya konulmas\u0131, h\u0131zl\u0131 ve anla\u015f\u0131l\u0131r olacak \u015fekilde t\u00fcm ilgili taraflara iletilmesi kritik \u00f6neme sahiptir.<\/p>\n<p>Uzla\u015f\u0131 Raporu ve Rehber niteli\u011findeki<strong>\u00a0<\/strong>bir yaz\u0131 a\u015fa\u011f\u0131daki gibi haz\u0131rlan\u0131r:<\/p>\n<ul>\n<li>Ba\u015fl\u0131k sayfas\u0131.<\/li>\n<li>Yap\u0131land\u0131r\u0131lmam\u0131\u015f T\u00fcrk\u00e7e \u00f6zet (en fazla 150 kelime), \u0130ngilizce \u00f6zet (en fazla 150 kelime) haz\u0131rlanmal\u0131d\u0131r.<\/li>\n<li>T\u00fcrk\u00e7e ve \u0130ngilizce anahtar kelimeler (en az 3 en \u00e7ok 6 adet ve Ulusal T\u0131p K\u00fct\u00fcphanesi (NLM) taraf\u0131ndan haz\u0131rlanan T\u0131bbi Konu Ba\u015fl\u0131klar\u0131 (MeSH) ile uyumlu olmak \u00fczere) verilmelidir.<\/li>\n<li><strong>Ana Metin:<\/strong> Ana metin Giri\u015f ve Y\u00f6ntem b\u00f6l\u00fcmleri ile ba\u015flamal\u0131d\u0131r. Di\u011fer b\u00f6l\u00fcmler ve ba\u015fl\u0131klar\u0131 yazarlar\u0131n uygun g\u00f6rd\u00fc\u011f\u00fc \u015fekilde alt ba\u015fl\u0131klara ayr\u0131labilir.<\/li>\n<li><strong>Giri\u015f: <\/strong>Yap\u0131lan \u00e7al\u0131\u015fman\u0131n amac\u0131, genel \u00e7er\u00e7evesi, hedef kitlesi ve co\u011frafi kapsam\u0131ndan olu\u015fur. \u00c7al\u0131\u015fma mevcut bir belgenin g\u00fcncellemesi ise neden bir g\u00fcncellemeye ihtiya\u00e7 duyuldu\u011fu aktar\u0131l\u0131r ve bir \u00f6nceki \u00e7al\u0131\u015fma ile aras\u0131ndaki en \u00f6nemli farklar ve de\u011fi\u015fiklikler izlenebilir (tablo, infografik, vb.) bir \u015fekilde \u00f6zetlenir.<\/li>\n<li><strong>Y\u00f6ntem: <\/strong>\u00c7al\u0131\u015fmay\u0131 y\u00f6nlendirenlerin rolleri ve uzmanl\u0131k alanlar\u0131\/deneyimleri, dahil edilme kriterleri belirtilir, kullan\u0131lan materyalin neler oldu\u011fu, kapsam\u0131 ve se\u00e7ilme kriterleri \u00f6zetlenir, kullan\u0131lan y\u00f6ntemler ve teknikler (\u00f6rne\u011fin, Delphi, RAND-UCLA, nominal grup tekni\u011fi, vb.) yaz\u0131l\u0131r. \u00c7al\u0131\u015fman\u0131n tarihsel olarak kapsam\u0131 belirtilmelidir.<\/li>\n<li>T\u00fcm b\u00f6l\u00fcmler ortak bir terminoloji ve dil birli\u011fi sa\u011flanm\u0131\u015f olarak yaz\u0131lmal\u0131d\u0131r.<\/li>\n<li>\u00c7al\u0131\u015fmay\u0131 y\u00f6netenler ve panelistler de dahil olmak \u00fczere olas\u0131 \u00e7\u0131kar \u00e7at\u0131\u015fmalar\u0131 belirtilmelidir. \u00c7\u0131kar \u00e7at\u0131\u015fmalar\u0131n\u0131n nas\u0131l y\u00f6netildi\u011fi a\u00e7\u0131klanmal\u0131d\u0131r.<\/li>\n<li><strong>Kaynaklar: <\/strong>A\u015fa\u011f\u0131da ayr\u0131nt\u0131s\u0131 verildi\u011fi \u015fekilde g\u00f6sterilmelidir. Say\u0131 s\u0131n\u0131rlamas\u0131 yoktur.<\/li>\n<li><strong>Tablo, \u015eekil ve Resimler: <\/strong>E\u011fer varsa metindeki ge\u00e7i\u015flerine g\u00f6re s\u0131ras\u0131yla numaraland\u0131r\u0131lmal\u0131; her birine k\u0131sa bir ba\u015fl\u0131k verilmeli ve ba\u015fl\u0131k tablolarda \u00fcst k\u0131sma, \u015fekil ve resimlerde alta yerle\u015ftirilmelidir. Di\u011fer ulusal ve uluslararas\u0131 uzla\u015f\u0131 raporu \/ rehberlerden ve bilimsel yay\u0131nlardan al\u0131nan tablo, \u015fekil ve resimler mutlaka izin al\u0131narak, kaynaktan bire bir al\u0131nd\u0131\u011f\u0131 ifade edilerek ve kaynak g\u00f6sterilerek verilmelidir. Kullan\u0131lacak hasta g\u00f6rselleri i\u00e7in mutlaka onam al\u0131nm\u0131\u015f olmal\u0131d\u0131r.<\/li>\n<\/ul>\n<h3 class=\"p6\"><b>G\u00f6r\u00fc\u015f\/Rapor<\/b><\/h3>\n<p>\u0130nfeksiyon hastal\u0131klar\u0131 ve klinik mikrobiyoloji alan\u0131nda s\u00f6z sahibi kurulu\u015f veya ki\u015filerin g\u00fcndemdeki \u00f6nemli konulara ili\u015fkin g\u00f6r\u00fc\u015f veya raporlar\u0131n\u0131 i\u00e7eren yaz\u0131lard\u0131r. Edit\u00f6ryal de\u011ferlendirmenin ard\u0131ndan dan\u0131\u015fman de\u011ferlendirmesine tabi tutulmaks\u0131z\u0131n yay\u0131mlan\u0131rlar. Kelime ve kaynak s\u0131n\u0131rlamas\u0131 bulunmamaktad\u0131r. Metin ba\u015fl\u0131klar\u0131 yazarlar taraf\u0131ndan belirlenir ve metne Kaynaklar eklenmelidir. Yap\u0131land\u0131r\u0131lmam\u0131\u015f T\u00fcrk\u00e7e \u00f6zet ve \u0130ngilizce \u00f6zet (her biri en fazla 150 kelime) haz\u0131rlanmal\u0131d\u0131r. Bu t\u00fcr yaz\u0131lardaki g\u00f6r\u00fc\u015fler yazar\u0131 ba\u011flad\u0131\u011f\u0131 gibi bu g\u00f6r\u00fc\u015flere ili\u015fkin dergi okuyucular\u0131 taraf\u0131ndan dergiye g\u00f6nderilen ele\u015ftiri ve katk\u0131lar da ayn\u0131 ba\u015fl\u0131k alt\u0131nda edit\u00f6ryal de\u011ferlendirmeden ge\u00e7irilerek yay\u0131mlanacakt\u0131r. B\u00f6ylelikle alan\u0131 ilgilendiren \u00f6nemli konularda bilimsel bir tart\u0131\u015fma platformu olu\u015fturulmas\u0131 planlanmaktad\u0131r.<\/p>\n<h3 class=\"p6\"><b>G\u00f6r\u00fcnt\u00fcden Tan\u0131ya<\/b><\/h3>\n<p>G\u00f6r\u00fcnt\u00fcden Tan\u0131ya yaz\u0131 t\u00fcr\u00fcnde, klinik, radyolojik, laboratuvar veya histopatolojik g\u00f6r\u00fcnt\u00fclerden yola \u00e7\u0131karak \u00f6zg\u00fcn, \u00f6\u011fretici ya da dikkat \u00e7ekici bir bulgu sunulur. Yaz\u0131 k\u0131sa tutulmal\u0131, ayr\u0131nt\u0131l\u0131 olgu \u00f6yk\u00fcs\u00fcne de\u011fil g\u00f6r\u00fcnt\u00fcn\u00fcn \u00f6zg\u00fcnl\u00fc\u011f\u00fcne ve tan\u0131sal de\u011ferine odaklan\u0131lmal\u0131d\u0131r. \u0130lgili bulgu k\u0131saca tart\u0131\u015f\u0131larak literat\u00fcr ile desteklenmelidir. Metin, Olgu ve Kaynaklar ba\u015fl\u0131klardan olu\u015fmal\u0131d\u0131r. Bu yaz\u0131 t\u00fcr\u00fc i\u00e7in \u00f6zet gerekli de\u011fildir. Kaynaklar hari\u00e7 ancak \u015fekil a\u00e7\u0131klamalar\u0131 dahil en fazla 500 kelime olmal\u0131d\u0131r. En fazla 4 yazar taraf\u0131ndan haz\u0131rlanabilir ve 5 kaynak i\u00e7erebilir. G\u00f6rseller y\u00fcksek \u00e7\u00f6z\u00fcn\u00fcrl\u00fckte olmal\u0131 ve a\u00e7\u0131klay\u0131c\u0131 alt yaz\u0131lar i\u00e7ermelidir. Yay\u0131nda yer alan klinik g\u00f6r\u00fcnt\u00fcler i\u00e7in hasta onam\u0131 al\u0131nmas\u0131 zorunludur.<\/p>\n<h3 class=\"p6\"><b>Edit\u00f6r G\u00f6r\u00fc\u015f\u00fc<\/b><\/h3>\n<p>Edit\u00f6r g\u00f6r\u00fc\u015f\u00fc, <em>Klimik Dergisi<\/em>\u2019nde yay\u0131mlanan bir orijinal makale ile ilgili olarak, makalenin konusuyla ilgili alanda uzman bir bilim insan\u0131 taraf\u0131ndan Ba\u015f Edit\u00f6r\u00fcn daveti \u00fczerine yaz\u0131lan yaz\u0131lard\u0131r. Edit\u00f6r g\u00f6r\u00fc\u015f\u00fcn\u00fcn, ilgili makaledeki bulgular\u0131 \u00f6zetleyerek bilim alan\u0131na katk\u0131s\u0131n\u0131 ve gelece\u011fe ili\u015fkin de\u011ferlendirmeleri i\u00e7ermesi beklenmektedir.<\/p>\n<p>Edit\u00f6r g\u00f6r\u00fc\u015f\u00fc t\u00fcr\u00fcndeki yaz\u0131lar a\u015fa\u011f\u0131daki \u015fekilde haz\u0131rlanmal\u0131d\u0131r:<\/p>\n<ul>\n<li>Ba\u015fl\u0131k sayfas\u0131.<\/li>\n<li><strong>Ana metin:<\/strong> Alt ba\u015fl\u0131klara ayr\u0131lmam\u0131\u015f olmal\u0131 ve en fazla 500 kelimeden olu\u015fmal\u0131d\u0131r.<\/li>\n<li><strong>Kaynaklar:<\/strong> A\u015fa\u011f\u0131da ayr\u0131nt\u0131s\u0131 verildi\u011fi \u015fekilde g\u00f6sterilmeli ve say\u0131s\u0131 5\u2019i a\u015fmamal\u0131d\u0131r.<\/li>\n<li><strong>Tablo, \u015fekil ve resimler:<\/strong> Bu yaz\u0131 t\u00fcr\u00fcnde en fazla bir tablo, \u015fekil veya resim bulunabilir.<\/li>\n<\/ul>\n<h3 class=\"p6\"><b>Edit\u00f6re Mektup<\/b><\/h3>\n<p>Edit\u00f6re Mektup,\u00a0<em>Klimik Dergisi<\/em>\u2019nde yay\u0131mlanm\u0131\u015f olan bir yaz\u0131 ile ilgili g\u00f6r\u00fc\u015f belirtmek veya\u00a0<em>Klimik Dergisi<\/em>\u2019nin ilgi alan\u0131na giren herhangi bir konuda g\u00f6r\u00fc\u015f bildirmek \u00fczere yay\u0131mlan\u0131r.<\/p>\n<p>Edit\u00f6re Mektup t\u00fcr\u00fcndeki bir yaz\u0131 a\u015fa\u011f\u0131daki gibi haz\u0131rlanmal\u0131d\u0131r:<\/p>\n<ul>\n<li>Ba\u015fl\u0131k sayfas\u0131.<\/li>\n<li><strong>Ana Metin:\u00a0<\/strong>Alt ba\u015fl\u0131klara ayr\u0131lmam\u0131\u015f olmal\u0131 ve en fazla 500 kelimeden olu\u015fmal\u0131d\u0131r.<\/li>\n<li><strong>Kaynaklar:\u00a0<\/strong>A\u015fa\u011f\u0131da ayr\u0131nt\u0131s\u0131 verildi\u011fi \u015fekilde g\u00f6sterilmeli ve say\u0131ca 5\u2019i a\u015fmamal\u0131d\u0131r.<\/li>\n<li><strong>Tablo, \u015eekil ve Resimler:\u00a0<\/strong>Bu yaz\u0131 tipinde en fazla bir tane tablo veya \u015fekil veya resim bulunmal\u0131d\u0131r.<\/li>\n<\/ul>\n<h2 class=\"p4\"><b>KAYNAKLAR<\/b><\/h2>\n<p>Kaynaklar i\u00e7in Amerikan Ulusal T\u0131p K\u00fct\u00fcphanesi\u2019nin (NLM) \u201c<strong>Citing Medicine\u201d<\/strong> referans stili temel al\u0131nmal\u0131d\u0131r. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK7256\/\">https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK7256\/<\/a><\/p>\n<p>Kaynaklar metinde yer ald\u0131klar\u0131 s\u0131rayla numaraland\u0131r\u0131lmal\u0131d\u0131r. Kaynak numaralar\u0131 metinde parantez i\u00e7inde verilmelidir. Sadece tablo, \u015fekil veya resim altyaz\u0131lar\u0131nda kullan\u0131lan kaynaklar, ilgili tablo veya \u015feklin metinde ge\u00e7ti\u011fi s\u0131raya g\u00f6re numaraland\u0131r\u0131lmal\u0131d\u0131r.<\/p>\n<p>Dergi adlar\u0131 MEDLINE\u2019da kullan\u0131lan k\u0131saltmalar ile yaz\u0131lmal\u0131d\u0131r. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/nlmcatalog\/journals\">https:\/\/www.ncbi.nlm.nih.gov\/nlmcatalog\/journals<\/a><\/p>\n<h3 class=\"p9\"><b>Dergi Makalesi<\/b><\/h3>\n<p><strong><em>En Fazla Alt\u0131 Yazarl\u0131<\/em><\/strong><\/p>\n<p>\u00c7elik M, Karabacak A, Arzu N, Ergon MC, Avkan-O\u011fuz V. [The impact of implementing a minimum evaluation bundle on clinical outcomes in the management of patients with\u00a0<em>Staphylococcus aureus<\/em>\u00a0bacteremia]. Klimik Derg. 2025;38(2):97\u2013102.Turkish. [<a href=\"https:\/\/doi.org\/10.36519\/kd.2025.5177\">CrossRef<\/a>]<\/p>\n<p><strong><em>\u00a0<\/em><\/strong><strong><em>Alt\u0131 Yazardan Fazla<\/em><\/strong><\/p>\n<p>Alves J, Schouten J, Thursky K, Paz RN, Rello J, Lye DC, et al; AMS Competencies Study Group. Establishing core competencies for antimicrobial stewardship teams: a consensus development using the modified Delphi technique-an European Society of Clinical Microbiology and Infectious Diseases Study Group for Antimicrobial Stewardship position paper. Clin Microbiol Infect. 2025;31(8):1313\u201320. [<a href=\"https:\/\/doi.org\/10.1016\/j.cmi.2025.04.035\">CrossRef<\/a>]<\/p>\n<h3 class=\"p6\"><b>Kitap B\u00f6l\u00fcm\u00fc<\/b><\/h3>\n<p><strong><em>Yazarl\u0131<\/em><\/strong><\/p>\n<p><strong>T\u00fcrk\u00e7e<br \/>\n<\/strong>Serter D. Vir\u00fcs, Riketsiya ve Klamidya Hastal\u0131klar\u0131. \u0130stanbul: Nobel T\u0131p Kitabevleri, 1997: 27\u201332.<\/p>\n<p><strong>Yabanc\u0131 Dil<br \/>\n<\/strong>Mims CA, Nash A, Stephen J. Mims\u2019 Pathogenesis of Infectious Diseases. 5th ed. San Diego: Academic Press, 2001: 361\u201391.<\/p>\n<p><strong><em>Edit\u00f6rleri Olan<\/em><\/strong><\/p>\n<p><strong>T\u00fcrk\u00e7e<br \/>\n<\/strong>Akta\u015f F. Antiviral ila\u00e7lar. In: Willke Top\u00e7u A, S\u00f6yletir G, Do\u011fanay M, eds. Enfeksiyon Hastal\u0131klar\u0131 ve Mikrobiyolojisi. 3. bask\u0131. \u0130stanbul: Nobel T\u0131p Kitabevleri, 2008: 399\u2013424.<\/p>\n<p><strong>Yabanc\u0131 Dil<br \/>\n<\/strong>Musher DM. Streptococcus pneumoniae. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Churchill Livingstone, 2005: 2392\u2013411.<\/p>\n<h3 class=\"p6\"><b>Kongre Kitab\u0131nda \u00d6zet<\/b><\/h3>\n<p><strong>T\u00fcrk\u00e7e<br \/>\n<\/strong>\u00d6zak\u0131n C, M\u0131st\u0131k R, Akdi\u015f AC. Uluda\u011f \u00dcniversitesi T\u0131p Fak\u00fcltesi \u0130nfeksiyon Hastal\u0131klar\u0131 Klini\u011fi\u2019nde son alt\u0131 y\u0131l i\u00e7inde izlenen bakteriyel menenjitlerin tan\u0131 ve tedavi a\u00e7\u0131s\u0131ndan de\u011ferlendirilmesi [\u00d6zet]. In: T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi (11\u201315 Eyl\u00fcl 1994, \u00dcrg\u00fcp) Kitab\u0131. \u0130stanbul: Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Derne\u011fi, 1994: 283\u20134.<\/p>\n<p><strong>Yabanc\u0131 Dil<br \/>\n<\/strong>Elaldi N, Kaya S, Dokmetas I, Yilmaz M, Bakir M, Ozkul A, et al. Markedly elevated serum cytokine levels and high viral titers in fatal Crimean-Congo hemorrhagic fever (CCHF) [Abstract]. In: Abstracts of the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago, IL, September 17\u201320, 2007). Washington (DC): American Society for Microbiology; 2007. p. 482.<\/p>\n<h3 class=\"p6\">\u0130nternet<\/h3>\n<p><strong><em>Yazarl\u0131<br \/>\n<\/em><\/strong>Shah A, Checkley W. Tularemia [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. [cited March 6, 2026]. Available from:<br \/>\n<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430905\/\">https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430905\/<\/a><\/p>\n<p><strong><em>Kurumsal<br \/>\n<\/em><\/strong>World Health Organization. Crimean-Congo haemorrhagic fever [Internet]. Geneva: WHO; February 20, 2025. [cited March 6, 2026]. Available from:<br \/>\n<a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/crimean-congo-haemorrhagic-fever\">https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/crimean-congo-haemorrhagic-fever<\/a><\/p>\n<h3 class=\"p6\">Tez<\/h3>\n<p><strong>T\u00fcrk\u00e7e<br \/>\n<\/strong>Kaya S. K\u0131r\u0131m-Kongo kanamal\u0131 ate\u015finde sitokin d\u00fczeylerinin klinik seyirle ili\u015fkisi [Uzmanl\u0131k Tezi]. Kayseri: Erciyes \u00dcniversitesi T\u0131p Fak\u00fcltesi; 2012.<\/p>\n<p><strong>Yabanc\u0131 Dil<br \/>\n<\/strong>Smith J. Molecular epidemiology of multidrug-resistant tuberculosis [dissertation]. London: University College London; 2018.<\/p>\n<h3 class=\"p6\">Standart\/K\u0131lavuz\/Rapor<\/h3>\n<ul>\n<li>European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters [Internet]. Version 14.0. V\u00e4xj\u00f6: EUCAST; 2024. [cited March 6, 2026]. Available from:<br \/>\n<a href=\"https:\/\/www.eucast.org\/clinical_breakpoints\/\">https:\/\/www.eucast.org\/clinical_breakpoints\/<\/a><\/li>\n<li>Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 33rd ed. CLSI supplement M100. Wayne (PA): CLSI; 2023.<\/li>\n<li>International Organization for Standardization. ISO 15189:2022. Medical laboratories \u2014 Requirements for quality and competence. Geneva: ISO; 2022.<\/li>\n<li>European Centre for Disease Prevention and Control. Annual epidemiological report for 2023: communicable diseases in Europe. Stockholm: ECDC; 2024.<\/li>\n<\/ul>\n<h3 class=\"p6\">Bask\u0131 \u00d6ncesi \u00c7evrim \u0130\u00e7i Yay\u0131mlanan Makale<\/h3>\n<p>Erg\u00f6n\u00fcl O, Whitehouse CA. Crimean-Congo hemorrhagic fever: progress and challenges. <strong>J Infect.<\/strong> 2024. doi:10.1016\/j.jinf.2024.01.015. Epub ahead of print.<\/p>\n<h3 class=\"p6\">\u00d6n Bask\u0131 (Preprint)<\/h3>\n<p>Smith J, Brown P, Lee K, Patel R, Gomez A, Chen Y, et al. Environmental persistence of SARS-CoV-2 on hospital surfaces <strong>[Preprint]<\/strong>.<strong> medRxiv<\/strong>. 2023. doi:10.1101\/2023.04.15.23288571.<\/p>\n<h2 class=\"p4\"><b>TABLOLAR, \u015eEK\u0130LLER VE RES\u0130MLER<\/b><\/h2>\n<p><em>Klimik Dergisi\u2019<\/em>nde g\u00f6nderilecek yaz\u0131larda tablolar, \u015fekiller ve resimler i\u00e7in a\u015fa\u011f\u0131daki hususlar uygulanmal\u0131d\u0131r:<\/p>\n<ul>\n<li>Tablolar\u0131n her biri ayr\u0131 bir sayfada olmal\u0131d\u0131r. Metindeki ge\u00e7i\u015flerine g\u00f6re s\u0131ras\u0131yla numaraland\u0131r\u0131lmal\u0131; her birine k\u0131sa bir ba\u015fl\u0131k verilmeli ve ba\u015fl\u0131k tablonun \u00fcst k\u0131sm\u0131na yerle\u015ftirilmelidir. Her s\u00fctuna k\u0131sa veya \u00f6zet bir ba\u015fl\u0131k verilmelidir. Yazarlar, a\u00e7\u0131klay\u0131c\u0131 nedenleri ba\u015fl\u0131\u011fa de\u011fil dipnotlara koymal\u0131d\u0131r. B\u00fct\u00fcn standart olmayan k\u0131saltmalar dipnotlarda a\u00e7\u0131klamal\u0131d\u0131r. Dipnotlarda s\u0131ras\u0131yla *, \u2020, \u2021, \u00a7, ||, \u00b6, **, \u2020\u2020, \u2021\u2021 sembolleri kullan\u0131lmal\u0131d\u0131r.<\/li>\n<li>\u015eekiller ve resimler metindeki ge\u00e7i\u015flerine g\u00f6re numaraland\u0131r\u0131lmal\u0131, y\u00fcksek \u00e7\u00f6z\u00fcn\u00fcrl\u00fckl\u00fc ve .jpg format\u0131nda olmal\u0131d\u0131r. \u015eekil ve resimlerin ba\u015fl\u0131klar\u0131 ve a\u00e7\u0131klamalar\u0131 altta yer almal\u0131d\u0131r.<\/li>\n<li>\u015eekiller ve resimler en az 300 dpi \u00e7\u00f6z\u00fcn\u00fcrl\u00fckte olmal\u0131d\u0131r.<\/li>\n<li>Grafik ve \u00e7izimler tercihen TIFF, JPG veya EPS format\u0131nda g\u00f6nderilmelidir.<\/li>\n<li>Hasta foto\u011fraflar\u0131nda kimli\u011fi ortaya \u00e7\u0131karabilecek bilgiler bulunmamal\u0131d\u0131r.<\/li>\n<li>Daha \u00f6nce yay\u0131mlanm\u0131\u015f tablo, \u015fekil veya resimlerin kullan\u0131m\u0131 i\u00e7in telif hakk\u0131 sahibinden yaz\u0131l\u0131 izin al\u0131nmal\u0131 ve kaynak belirtilmelidir.<\/li>\n<\/ul>\n<h2>DEPOLAMA POL\u0130T\u0130KASI<\/h2>\n<p><em>Klimik Dergisi<\/em>, bir dergi y\u00f6netim sistemi olan\u00a0<a href=\"http:\/\/klimik.dergisi.org\/login.php?page=0\"><strong><em>Pleksus<\/em><\/strong>&#8216;<\/a>u kullan\u0131r ve\u00a0<a href=\"http:\/\/klimik.dergisi.org\/login.php?page=0\"><strong><em>Pleksus<\/em><\/strong><\/a>&#8216;taki yaz\u0131lar\u0131n g\u00f6nderilen, g\u00f6zden ge\u00e7irilen, kabul edilen ve yay\u0131nlanan versiyonlar\u0131n\u0131 ar\u015fivler. Yazarlar\u0131n t\u00fcm bu s\u00fcr\u00fcmlere herhangi bir engel olmadan ula\u015fmalar\u0131na izin verilir.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Klimik Dergisi\u2019nin edit\u00f6rl\u00fck ve yay\u0131n s\u00fcre\u00e7leri \u201cInternational Committee of Medical Journal Editors (ICMJE)\u201d, \u201cWorld Association of Medical Editors (WAME)\u201d, \u201cCouncil of Science Editors (CSE)\u201d, \u201cCommittee on Publication Ethics (COPE)\u201d, \u201cEuropean Association of Science Editors (EASE)\u201d ve \u201cNational Information Standards Organization (NISO)\u201d organizasyonlar\u0131n\u0131n k\u0131lavuzlar\u0131na uygun olarak tasarlanm\u0131\u015ft\u0131r ve \u201cPrinciples of Transparency and Best Practice in Scholarly [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":18,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-22","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/pages\/22","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/comments?post=22"}],"version-history":[{"count":4,"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/pages\/22\/revisions"}],"predecessor-version":[{"id":31583,"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/pages\/22\/revisions\/31583"}],"wp:attachment":[{"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/media?parent=22"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}